Actively Recruiting
Ketamine Assisted Psychotherapy for Opioid Use Disorder
Led by University of Utah · Updated on 2023-07-05
60
Participants Needed
1
Research Sites
158 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This pilot clinical trial aims to assess the preliminary efficacy of ketamine as an adjunct for a mindfulness-based intervention for opioid use disorder.
CONDITIONS
Official Title
Ketamine Assisted Psychotherapy for Opioid Use Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Opioid Use Disorder
- Currently receiving opioid use disorder treatment with a buprenorphine formulation
You will not qualify if you...
- Previous experience with a mindfulness-based intervention program
- Pregnancy
- Any serious medical, mental, or cognitive condition preventing participation in mindfulness-based group treatment
- Prior ketamine use other than prescribed by a physician
- Presence of any of the following medical conditions: Blood Vessel Disease, Heart Valve Disease, Heart Failure Class 2 or above, Heart Disease, Pregnancy/Breastfeeding, Arteriovenous Malformation, History of Intracranial Bleeding or Stroke, History of Seizures, Hypoxia needing supplemental oxygen, Liver Disease, History of allergic reaction to Ketamine, Moderate to severe Dementia, History of Psychotic Disorder, Bipolar Disorder, Personality Disorder, or Dissociative Identity Disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Center on Mindfulness and Integrative Health Intervention Development
Salt Lake City, Utah, United States, 84112
Actively Recruiting
Research Team
R
Research Coordinator
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here